The Heart Failure Nurse Service

Slides:



Advertisements
Similar presentations
Practicalities of Palliative Care
Advertisements

Advanced Heart Failure and the Role of Mechanical Circulatory Support
LIFE-LIMITING ILLNESS
THE ROLE OF THE CARDIAC NURSE PRACTITIONER
Congestive Heart Failure
Congestive heart failure
SYMPTOM CONTROL FOR ADVANCED RESPIRATORY DISEASE
1 Heart Failure William Chavey, MD, MS Associate Professor Department of Family Medicine University of Michigan.
Heart Failure: Living with a Hurting Heart. Congestive Heart Failure Heart (or cardiac) failure is the state in which the heart is unable to pump blood.
Prepared by : Nehad J. Ahmed.  Heart failure, also known as congestive heart failure (CHF), means your heart can't pump enough blood to meet your body's.
Heart Failure Whistle Stop Talks No 1 HFrEF and HFpEF Definitions for Diagnosis Susie Bowell BA Hons, RGN Heart Failure Specialist Nurse.
Dr. Jon Salisbury Visiting Physician Services A Member of VNA Health Group No Disclosures May 14, :40PM – 2:00PM ©AAHCM.
Congestive Heart Failure PATIENT INFORMATION BY: LASHONDA MARTIN.
THE ROLE OF THE HEART FAILURE SPECIALIST NURSE NHS Grampian Heart Failure Nurses November 2008.
Clinical Knowledge Summaries CKS Heart failure - chronic Primary care management of end stage chronic heart failure. Educational slides based on the CKS.
Community Nurse Inreach(CNIR) Providing safe & effective nursing across the Hospital & Community Interface. Appendix 9.
Drugs for CCF Heart failure is the progressive inability of the heart to supply adequate blood flow to vital organs. It is classically accompanied by significant.
Modern Management of heart Failure Dr Amanda Varnava Consultant Cardiologist Watford & St Mary’s Hospitals.
Heart Failure Core Measures GMEC QI Presentation.
Evaluation of a community based heart failure programme. Authors. Anita Bell, Public Health Physician Veronique Gibbons, Research Fellow in Primary Care.
CHARM-Alternative: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Alternative Purpose To determine whether the angiotensin.
HEART FAILURE Prevalence increasing in our ageing population Incidence doubles with each decade between 40 and 80 At any age more common in men than women.
Heart Failure Jeopardy DrugsSelf-Care Patient Eval Volume Mgt Misc.
Causes Myocardial dysfunction eg IHD, CM Volume overload eg AR, MR Obstruction eg AS, HCM Diastolic dysfunction eg Constriction Mechanical problems eg.
Medical Progress: Heart Failure. Primary Targets of Treatment in Heart Failure. Treatment options for patients with heart failure affect the pathophysiological.
To know more visit HeartFailure.com © 2015 Novartis Pharma AG, May 2015, GLCM/HTF/0028 HEART FAILURE DISEASE MANAGEMENT STANDARDS.
Heart Failure Palliative Care/Heart Failure Audit.
Chronic Heart Failure Clinical case scenarios for primary care Educational Resource Implementing NICE guidance August 2010 NICE clinical guideline 108.
Cardiac Failure Richard Price Richard Price Consultant, Intensive Care, RAH. Consultant, Intensive Care, RAH.
Nursing and heart failure
Heart Failure Heart is unable to pump sufficient blood to meet the needs of the body. It is key symptoms are dyspnea, fatigue, fluid retention. HF is.
TREATMENT OF HEART FAILURE From Oral Medications to Intravenous Drips Mark Puhlman MSN ANP.
Systolic Versus Diastolic Failure. Forms of Heart Failure Sytolic Failure Inability of the ventricle to contract normally and expel sufficient blood Inadequate.
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
Jennifer Bell British Heart Foundation Heart Failure Nurse Specialist.
Palliative Care In Heart Failure Dr Chi-Chi Cheung Consultant in Palliative Medicine 19 th March 2015.
HEART FAILURE Jamil Mayet Consultant Cardiologist.
Internal Medicine Workshop Series Laos September /October 2009
CHF Team Approach Peter Carson, MD Jacqueline Gannuscio, MSN, ACNP RN Washington DC.
PHARMACOLOGIC THERAPY  Standard First-Line Therapies Angiotensin-Converting Enzyme Inhibitors (ACEI) β Blockers Diuretics Digoxin  Second line Therapies.
Internal Medicine Workshop Series Laos September /October 2009.
Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Quality of Care of and Outcomes for African Americans.
Heart Failure Services at STH: How it works and how End of Life issues are addressed Dr Soon H Song Consultant Diabetologist Acute Medicine Lead for STH.
HEART FAILURE TEAM MEMBERSHIP DEPARTMENTS OF CARDIOLOGY, CARDIOVASCULAR SURGERY, MEDICINE, NURSING, QUALITY AND RESOURCE MANAGEMENT, THE CENTER FOR CLINICAL.
Ridha Chakeer MD PGY3. Objectives: Approximately 5.2 million Americans are affected  accounts for more than 3 million outpatient visits to primary care.
신장내과 R4 강혜란 Cardiorenal syndrome (CRS).  Patients with heart failure (HF) who have a reduced GFR -> Mortality ↑  Patients with chronic kidney disease.
Dr Dylan Harris Dr Mel Jefferson
Chronic heart failure By Vishal Patel GPVTS1.
Fig ACCF/AHA Guideline for the management of heart failure
Clinical Knowledge Summaries CKS Heart failure - chronic
These slides highlight a presentation at the Late Breaking Trial Session of the American College of Cardiology 52nd Annual Scientific Sessions in Chicago,
Guideline: Chronic Heart Failure
Heart failure.
Heart Failure The inability of the heart to pump sufficient blood to meet the needs of the tissues for oxygen and nutrients. A syndrome characterized.
Heart Failure Care at UC Davis
Heart Failure - Summary
Congestive heart failure
Chapter 28 Management of Patients With Coronary Vascular Disorders
Patients with implantable defibrillators are out there and coming your way
Step Care Therapy for Hypertension in Diabetic Patients
West Essex Frailty Pathway: Heart Failure
Section III: Neurohormonal strategies in heart failure
Stepwise treatment of patients with symptomatic (NYHA II–IV) heart failure with reduced ejection fraction. Stepwise treatment of patients with symptomatic.
Fig. 2. Evidence-based medication prescriptions
Shannon M. Dunlay, MD, MS, Naveen L. Pereira, MD, Sudhir S
Dr Satti Abdelrahim Satti Pediatric Consultant
BHF Community Heart Failure Specialist Team
β-Blocker Use for the Stages of Heart Failure
Stepwise treatment of patients with symptomatic (NYHA II–IV) heart failure with reduced ejection fraction. Stepwise treatment of patients with symptomatic.
Flow diagram of the recommended pharmacological management of heart failure adapted from the European Society of Cardiology guidelines Flow diagram.
Presentation transcript:

The Heart Failure Nurse Service Managing Patients with Left Ventricular Systolic Dysfunction in Tayside

The HFNLS 3 Nurses Tayside wide Managing patients with LVSD who have had a hospital admission with heart failure or presented at clinic with unstable symptoms. Aim: Promoting Patient Understanding of Their Condition Facilitating Self Management Symptom management Improving prognosis Co-ordinating End of Life Care

Self Management Daily Weighing (to assess fluid retention) Fluid restriction Salt restriction Symptom monitoring Encouraging Medication Compliance Managing and Pacing Activity Management of Breathlessness

Symptoms Common Symptoms Breathlessness: on exertion, orthopnoea & PND Ankle & Leg Swelling and/or Abdominal Ascites Fatigue Advanced Symptoms Nausea (caused by gut oedema) Breathlessness at rest Itch (renal disease or liver congestion) Cachexia and poor appetite Hypoxic Confusion

Palliation of HF Symptoms We Have an Array of Proven Medications & Therapies Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Entresto (Sacubitril/Valsartan) Beta Blockers/Ivabradine Duiretics: Loop and Thiazide Aldosterone Antagonists Digoxin Cardiac Resynchronisation Therapy Device/ICD

End Stage Heart Failure Frequent Hospital Admissions with decompensated HF Symptomatic of Heart Failure with Poor response to Standard Heart Failure Medication (particularly high dose IV or Oral diuretics). Reduction in Functional Capacity Cardiac Cachexia Symptoms of End Organ Disease (deteriorating renal function and or liver function)

Case Study 1 ICD Deactivation in End Stage Heart Failure 59 year old man, Extensive MI 1 Year previous, CRT-D in situ, Cachexic, Fluid overloaded, BP 82/64mm Hg, pulse 60bpm(paced), Functional Capacity very limited, Breathlessness & Anxiety. Discussing End of Life, Advanced Care Planning. Discussing ICD deactivation. The practicalities: Where and When. The alternatives (Magnet in the home with instruction). The outcome a very peaceful death at home

Case Study 2 Palliative Care Team Input 65 year old male, previous coronary artery bypass, Grossly fluid overloaded (no response to IV or oral diuretics). Breathless and nauseated because of gut oedema Specialist Palliative Care Symptom Control Clinics (Nausea, Itch, Pain, Breathlessness) Advanced Care Planning; Choice of Place of Death was Hospice End of Life Care in Hospice a peaceful death achieved.

Team Work Is Necessary Cardiology Team including Heart Failure Nurse Renal Team Palliative Care Team General Practitioner District Nursing Team Carers At end of life it is not possible to achieve a satisfactory outcome for the patient and family without advanced planning and team work. All of the above may have their role to play. At end of life the most important may well be the Team of Carer’s and the District Nursing Team.

In Summary The Trajectory of Disease Progression in Heart Failure is uncertain. Palliation of Heart Failure Symptoms is through optimisation of Medication/Devices and optimising the environment. Discussions regarding end of life and defibrillator switch off need to take place in good time. In latter stages advice may be required regarding medication for symptom control out with standard cardiac medication (Mirtazepine, Haloperidol, Oxycodone etc) A team approach is required to bring about satisfactory care at end of life for heart failure patients.